JBT Marel (JBTM) recently hosted an Investor Day in New York City, where leadership laid out business priorities, key growth initiatives, and 2028 financial targets, providing investors with additional detail on the company’s direction.
See our latest analysis for JBT Marel.
The 1 month share price return of 19.81% and 90 day share price return of 20.51% point to fading short term momentum, even though the 1 year total shareholder return of 1.33% and 3 year total shareholder return of 14.19% indicate a more resilient longer term picture.
If this Investor Day has you reassessing opportunities in industrial automation and processing, it could be a good moment to broaden your search with 33 robotics and automation stocks
With JBT Marel shares down over the past month but trading at a reported 41% intrinsic discount and a 47% gap to analyst targets, the key question is simple: is this genuine value or is future growth already priced in?
Most Popular Narrative: 32.2% Undervalued
With JBT Marel last closing at $123.50 against a narrative fair value of $182.08, the current pricing sits well below what the most followed narrative assumes is justified. This sets up a valuation debate that centers on growth, margins, and how the combined business scales over time.
The JBT Marel merger is already realizing synergy benefits, enabling margin expansion through cost savings, portfolio breadth, increased cross-selling, and a deeper customer relationship via integrated system sales, which management expects to continue driving net margin improvement into 2027.
Read the complete narrative. Read the complete narrative.
Want to understand why this framework points to a higher fair value? The core of the narrative leans on revenue compounding, thicker margins, and a future earnings profile that assumes a premium P/E multiple. Curious which growth and profitability assumptions need to line up for that to hold?
Result: Fair Value of $182.08 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on merger integration staying on track and on tariff or supply chain pressures not eroding the earnings profile that analysts are building into their models.
Find out about the key risks to this JBT Marel narrative.
Next Steps
Seeing both optimism and concern in this story so far? Take a moment to weigh those signals for yourself and check the 3 key rewards and 1 important warning sign
Looking for more investment ideas?
Do not stop your research with a single stock; broaden your options now and give yourself more ways to put your capital to work intelligently.
- Target potential mispricing by scanning companies that combine quality fundamentals with attractive valuations using the 62 high quality undervalued stocks.
- Strengthen your income stream by reviewing companies with robust payout profiles and higher yields through the 12 dividend fortresses.
- Reduce portfolio stress by spotting companies that score well on resilience and risk using the 64 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com